<!DOCTYPE html>
<html class="client-js"><head>
  <meta charset=UTF-8"UTF-8">
  <title>Rabeprazole</title>
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <script>
    function importScript() { return 1 } // this is to avoid the error from site.js
  </script>
  <link rel="canonical" href="https://en.wikipedia.org/wiki/Rabeprazole">
  <link href="../-/s/css_modules/ext.cite.ux-enhancements.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.ux-enhancements.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/ext.cite.styles.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.styles.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/fi000001.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/skins.minerva.base.reset|skins.minerva.content.styles|ext.cite.style|site.styles|mobile.app.pagestyles.android|mediawiki.page.gallery.styles|mediawiki.skinning.content.parsoid.css" rel="stylesheet" type="text/css" class="">
  <link href="../-/s/css_modules/style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/style.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/content.parsoid.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/content.parsoid.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/inserted_style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/inserted_style.css" rel="stylesheet" type="text/css" class="">
  <script src="../-/j/js_modules/script.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/script.js" class=""></script><script src="../-/j/js_modules/masonry.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/masonry.min.js" class=""></script><script src="../-/j/js_modules/article_list_home.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/article_list_home.js" class=""></script><script src="../-/j/js_modules/images_loaded.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/images_loaded.min.js" class=""></script><script src="../-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" class=""></script>
<link type="root" href=""></head>

<body class="mediawiki mw-hide-empty-elt ns-0 ns-subject stable skin-minerva action-view animations">
  <div id="mw-mf-viewport" class="feature-header-v2">
    <div id="mw-mf-page-center">
      <div id="content" class="mw-body">
        <a id="top"></a>
        <div id="bodyContent" class="content mw-parser-output">
          
          <div id="mw-content-text" style="direction: ltr;"><h1 class="section-heading" tabindex="0" aria-haspopup="true" data-section-id="0">
  <span class="mw-headline" id="title_0">Rabeprazole</span>
</h1>
<div id="mf-section-0" class="mf-section-0" aria-pressed="true" aria-expanded="true">
  <p><b>Rabeprazole</b>, sold under the brand name <b>Pariet</b> among others, is a medication that decreases stomach acid.<span class="mw-ref" id="cite_ref-AHFS2019_6-0"><a href="#cite_note-AHFS2019-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span> It is used to treat peptic ulcer disease, gastroesophageal reflux disease, and excess stomach acid production such as in Zollinger–Ellison syndrome.<span class="mw-ref" id="cite_ref-AHFS2019_6-1"><a href="#cite_note-AHFS2019-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span> It may also be used in combination with other medications to treat <i>Helicobacter pylori</i>.<span class="mw-ref" id="cite_ref-BNF76_7-0"><a href="#cite_note-BNF76-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span> Effectiveness is similar to other proton pump inhibitors (PPIs).<span class="mw-ref" id="cite_ref-TI2016_8-0"><a href="#cite_note-TI2016-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span> It is taken by mouth.<span class="mw-ref" id="cite_ref-AHFS2019_6-2"><a href="#cite_note-AHFS2019-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span></p>


<p></p>

<table class="infobox" style="width:22em;border-spacing:2px;"><caption><span>Rabeprazole</span></caption><tbody><tr><td colspan="2" style="text-align:center"><figure-inline><img src="../I/m/Rabeprazole.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Rabeprazole.svg.png" data-file-width="512" data-file-height="279" data-file-type="drawing" height="131" width="240"></figure-inline></td></tr><tr><td colspan="2" style="text-align:center"><figure-inline><img src="../I/m/Rabeprazole3d.png" tppabs="https://ptable.com/wiki/compounds/I/m/Rabeprazole3d.png" data-file-width="1000" data-file-height="500" data-file-type="bitmap" height="120" width="240"></figure-inline></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Clinical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Pronunciation</th><td><span class="rt-commentedText nowrap"><span class="IPA nopopups noexcerpt">/<span style="border-bottom:1px dotted"><span>r</span><span>ə</span><span>ˈ</span><span>b</span><span>ɛ</span><span>p</span><span>r</span><span>ə</span><span>ˌ</span><span>z</span><span>ɔː</span><span>l</span></span>/</span></span><span> </span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Trade names</th><td>Aciphex, Pariet, others</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">AHFS/Drugs.com</th><td><span><a href="javascript:if(confirm('https://www.drugs.com/monograph/rabeprazole-sodium.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/monograph/rabeprazole-sodium.html'" tppabs="https://www.drugs.com/monograph/rabeprazole-sodium.html" class="external text external">Monograph</a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">MedlinePlus</th><td><span><a href="javascript:if(confirm('https://medlineplus.gov/druginfo/meds/a699060.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://medlineplus.gov/druginfo/meds/a699060.html'" tppabs="https://medlineplus.gov/druginfo/meds/a699060.html" class="external text external">a699060</a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">License data</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">US</abbr></small><span>&nbsp;</span>DailyMed:<span>&nbsp;</span><span><a href="javascript:if(confirm('https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Rabeprazole  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Rabeprazole'" tppabs="https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Rabeprazole" class="external text external">Rabeprazole</a></span></li>
<li><small><abbr class="country-name">US</abbr></small><span>&nbsp;</span><span>FDA:<span>&nbsp;</span><a href="javascript:if(confirm('https://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&SearchTerm=Rabeprazole&SearchType=BasicSearch  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&SearchTerm=Rabeprazole&SearchType=BasicSearch'" tppabs="https://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&SearchTerm=Rabeprazole&SearchType=BasicSearch" class="external text external">Rabeprazole</a></span></li></ul></div>
</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Pregnancy<br>category</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">AU</abbr>:</small><span> </span>B1<span> </span><span class="mw-ref" id="cite_ref-Drugs.com_pregnancy_1-0"><a href="#cite_note-Drugs.com_pregnancy-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></li>
<li><small><abbr class="country-name">US</abbr>:</small><span> </span>N (Not classified yet)<span> </span><span class="mw-ref" id="cite_ref-Drugs.com_pregnancy_1-1"><a href="#cite_note-Drugs.com_pregnancy-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></li></ul>

<ul></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Routes of<br>administration</th><td>By mouth</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Drug class</th><td>Proton pump inhibitor<span class="mw-ref" id="cite_ref-Marelli_Review_2012_2-0"><a href="#cite_note-Marelli_Review_2012-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ATC code</th><td><div class="plainlist"><ul><li>A02BC04<span> </span>(<span><a href="javascript:if(confirm('https://www.whocc.no/atc_ddd_index/?code=A02BC04  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.whocc.no/atc_ddd_index/?code=A02BC04'" tppabs="https://www.whocc.no/atc_ddd_index/?code=A02BC04" class="external text external">WHO</a></span>)<span> </span>A02BC54<span> </span>(<span><a href="javascript:if(confirm('https://www.whocc.no/atc_ddd_index/?code=A02BC54  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.whocc.no/atc_ddd_index/?code=A02BC54'" tppabs="https://www.whocc.no/atc_ddd_index/?code=A02BC54" class="external text external">WHO</a></span>) A02BD12<span> </span>(<span><a href="javascript:if(confirm('https://www.whocc.no/atc_ddd_index/?code=A02BD12  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.whocc.no/atc_ddd_index/?code=A02BD12'" tppabs="https://www.whocc.no/atc_ddd_index/?code=A02BD12" class="external text external">WHO</a></span>) A02BD13<span> </span>(<span><a href="javascript:if(confirm('https://www.whocc.no/atc_ddd_index/?code=A02BD13  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.whocc.no/atc_ddd_index/?code=A02BD13'" tppabs="https://www.whocc.no/atc_ddd_index/?code=A02BD13" class="external text external">WHO</a></span>)</li></ul></div></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Legal status</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Legal status</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">UK</abbr>:</small><span> </span>POM (Prescription only)<span> </span></li>
<li><small><abbr class="country-name">US</abbr>:</small><span> </span>℞-only<span> </span></li></ul></div>
</td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Pharmacokinetic data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Bioavailability</th><td>52%<span class="mw-ref" id="cite_ref-Marelli_Review_2012_2-1"><a href="#cite_note-Marelli_Review_2012-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Protein binding</th><td>96.3%<span class="mw-ref" id="cite_ref-Langtry_Review_3-0"><a href="#cite_note-Langtry_Review-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Metabolism</th><td>CYP2C19 and CYP3A4 in the liver<span class="mw-ref" id="cite_ref-Marelli_Review_2012_2-2"><a href="#cite_note-Marelli_Review_2012-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Metabolites</th><td>thioether carboyxlic acid metabolite, thioether glucuronide metabolite, sulfone metabolite<span class="mw-ref" id="cite_ref-Langtry_Review_3-1"><a href="#cite_note-Langtry_Review-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Elimination <span class="nowrap">half-life</span></th><td>~1 hour<span class="mw-ref" id="cite_ref-Marelli_Review_2012_2-3"><a href="#cite_note-Marelli_Review_2012-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Excretion</th><td>90% via kidney as metabolites<span class="mw-ref" id="cite_ref-PubChem_4-0"><a href="#cite_note-PubChem-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span><span class="mw-ref" id="cite_ref-5"><a href="#cite_note-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Identifiers</th></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">IUPAC name</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; text-align:left; padding-left:1.5em; text-indent:-1.5em; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><span style="font-size: 11px;">(<i>RS</i>)-2-([4-(3-Methoxypropoxy)-3-methylpyridin-2-yl]methylsulfinyl)-1<i>H</i>-benzo[<i>d</i>]imidazole</span></li></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CAS Number</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.commonchemistry.org/ChemicalDetail.aspx?ref=117976-89-3  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.commonchemistry.org/ChemicalDetail.aspx?ref=117976-89-3'" tppabs="http://www.commonchemistry.org/ChemicalDetail.aspx?ref=117976-89-3" class="external text external">117976-89-3</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">PubChem <span style="font-weight:normal"><abbr>CID</abbr></span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://pubchem.ncbi.nlm.nih.gov/compound/5029  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubchem.ncbi.nlm.nih.gov/compound/5029'" tppabs="https://pubchem.ncbi.nlm.nih.gov/compound/5029" class="external text external">5029</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">IUPHAR/BPS</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7290  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7290'" tppabs="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7290" class="external text external">7290</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">DrugBank</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.drugbank.ca/drugs/DB01129  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugbank.ca/drugs/DB01129'" tppabs="https://www.drugbank.ca/drugs/DB01129" class="external text external">DB01129</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChemSpider</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.chemspider.com/Chemical-Structure.4853.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.chemspider.com/Chemical-Structure.4853.html'" tppabs="http://www.chemspider.com/Chemical-Structure.4853.html" class="external text external">4853</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">UNII</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=32828355LL  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=32828355LL'" tppabs="https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=32828355LL" class="external text external">32828355LL</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">KEGG</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.kegg.jp/entry/D08463  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.kegg.jp/entry/D08463'" tppabs="https://www.kegg.jp/entry/D08463" class="external text external">D08463</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li><li><span><a href="javascript:if(confirm('https://www.kegg.jp/entry/C07864  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.kegg.jp/entry/C07864'" tppabs="https://www.kegg.jp/entry/C07864" class="external text external">C07864</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChEBI</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:8768  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:8768'" tppabs="https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:8768" class="external text external">CHEBI:8768</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChEMBL</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL1219  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL1219'" tppabs="https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL1219" class="external text external">ChEMBL1219</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">PDB ligand</th><td><div class="plainlist"><ul><li>RZX (<span><a href="javascript:if(confirm('https://www.ebi.ac.uk/pdbe-srv/PDBeXplore/ligand/?ligand=RZX  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/pdbe-srv/PDBeXplore/ligand/?ligand=RZX'" tppabs="https://www.ebi.ac.uk/pdbe-srv/PDBeXplore/ligand/?ligand=RZX" class="external text external">PDBe</a></span>, <span><a href="javascript:if(confirm('http://www.rcsb.org/pdb/search/smartSubquery.do?smartSearchSubtype=ChemCompIdQuery&chemCompId=RZX&polymericType=Any  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.rcsb.org/pdb/search/smartSubquery.do?smartSearchSubtype=ChemCompIdQuery&chemCompId=RZX&polymericType=Any'" tppabs="http://www.rcsb.org/pdb/search/smartSubquery.do?smartSearchSubtype=ChemCompIdQuery&chemCompId=RZX&polymericType=Any" class="external text external">RCSB<span>&nbsp;</span>PDB</a></span>)</li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CompTox Dashboard <span style="font-weight:normal">(<abbr>EPA</abbr>)</span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://comptox.epa.gov/dashboard/DTXSID3044122  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://comptox.epa.gov/dashboard/DTXSID3044122'" tppabs="https://comptox.epa.gov/dashboard/DTXSID3044122" class="external text external">DTXSID3044122</a> <figure-inline class="mw-valign-text-top"><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></figure-inline></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;"><span>ECHA InfoCard</span></th><td><a href="javascript:if(confirm('https://echa.europa.eu/substance-information/-/substanceinfo/100.123.408  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://echa.europa.eu/substance-information/-/substanceinfo/100.123.408'" tppabs="https://echa.europa.eu/substance-information/-/substanceinfo/100.123.408" class="external text external">100.123.408</a> <figure-inline class="mw-valign-text-top"><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></figure-inline></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Chemical and physical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Formula</th><td><span>C</span><sub>18</sub><span>H</span><sub>21</sub><span>N</span><sub>3</sub><span>O</span><sub>3</sub><span>S</span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Molar mass</th><td><span class="nowrap">359.44</span><span>&nbsp;</span>g·mol<sup>−1</sup></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">3D model (JSmol)</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://chemapps.stolaf.edu/jmol/jmol.php?model=CC1%3DC%28C%3DCN%3DC1CS%28%3DO%29C2%3DNC3%3DCC%3DCC%3DC3N2%29OCCCOC  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://chemapps.stolaf.edu/jmol/jmol.php?model=CC1%3DC%28C%3DCN%3DC1CS%28%3DO%29C2%3DNC3%3DCC%3DCC%3DC3N2%29OCCCOC'" tppabs="https://chemapps.stolaf.edu/jmol/jmol.php?model=CC1%3DC%28C%3DCN%3DC1CS%28%3DO%29C2%3DNC3%3DCC%3DCC%3DC3N2%29OCCCOC" class="external text external">Interactive image</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Chirality</th><td>Racemic mixture<span class="mw-ref" id="cite_ref-Marelli_Review_2012_2-4"><a href="#cite_note-Marelli_Review_2012-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">SMILES</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCCCOC</div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">InChI</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">InChI=1S/C18H21N3O3S/c1-13-16(19-9-8-17(13)24-11-5-10-23-2)12-25(22)18-20-14-6-3-4-7-15(14)21-18/h3-4,6-9H,5,10-12H2,1-2H3,(H,20,21)<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></div></li><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">Key:YREYEVIYCVEVJK-UHFFFAOYSA-N<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><style data-mw-deduplicate="TemplateStyles:r886047488">.mw-parser-output .nobold{font-weight:normal}</style><span class="nobold"><span>&nbsp;</span><span>&nbsp;</span><span class="reflink  nourlexpansion"><a href="javascript:if(confirm('https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=462080585&page2=Rabeprazole  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=462080585&page2=Rabeprazole'" tppabs="https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=462080585&page2=Rabeprazole" class="external text external">(verify)</a></span></span></td></tr></tbody></table>


<p>Common side effects include constipation, feeling weak, and throat inflammation.<span class="mw-ref" id="cite_ref-AHFS2019_6-3"><a href="#cite_note-AHFS2019-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span> Serious side effects may include osteoporosis, low blood magnesium, <i>Clostridium difficile</i> infection, and pneumonia.<span class="mw-ref" id="cite_ref-AHFS2019_6-4"><a href="#cite_note-AHFS2019-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span> Use in pregnancy and breastfeeding is of unclear safety.<span class="mw-ref" id="cite_ref-Drugs.com_pregnancy_1-2"><a href="#cite_note-Drugs.com_pregnancy-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> It works by blocking H<sup>+</sup>/K<sup>+</sup>-ATPase in the parietal cells of the stomach.<span class="mw-ref" id="cite_ref-AHFS2019_6-5"><a href="#cite_note-AHFS2019-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span></p>


<p>Rabeprazole was patented in 1986, and approved for medical use in 1997.<span class="mw-ref" id="cite_ref-9"><a href="#cite_note-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span> It is available as a generic medication.<span class="mw-ref" id="cite_ref-BNF76_7-1"><a href="#cite_note-BNF76-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span> A month supply in the United Kingdom costs the NHS about <span style="white-space: nowrap">GB£1</span> as of 2019.<span class="mw-ref" id="cite_ref-BNF76_7-2"><a href="#cite_note-BNF76-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span> In the United States the wholesale cost of this amount is about <span style="white-space: nowrap">US$11</span>.<span class="mw-ref" id="cite_ref-NADAC2019_10-0"><a href="#cite_note-NADAC2019-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span> In 2017, it was the 279th most commonly prescribed medication in the United States, with more than one million prescriptions.<span class="mw-ref" id="cite_ref-11"><a href="#cite_note-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span><span class="mw-ref" id="cite_ref-12"><a href="#cite_note-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span></p>
<style data-mw-deduplicate="TemplateStyles:r886046785">.mw-parser-output .toclimit-2 .toclevel-1 ul,.mw-parser-output .toclimit-3 .toclevel-2 ul,.mw-parser-output .toclimit-4 .toclevel-3 ul,.mw-parser-output .toclimit-5 .toclevel-4 ul,.mw-parser-output .toclimit-6 .toclevel-5 ul,.mw-parser-output .toclimit-7 .toclevel-6 ul{display:none}</style><div class="toclimit-3"><meta property="mw:PageProp/toc"></div>


</div><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Medical_uses">Medical uses</h2></summary>
    
<div class="thumb tleft"><div class="thumbinner" style="width:222px"><img src="../I/m/Aciphex-20b.jpg" tppabs="https://ptable.com/wiki/compounds/I/m/Aciphex-20b.jpg" data-file-width="2004" data-file-height="900" data-file-type="bitmap" height="99" width="220"><div class="thumbcaption" style="text-align: left">Brand-name rabeprazole.</div></div></div>
<div class="thumb tright"><div class="thumbinner" style="width:222px"><img src="../I/m/Aciphex-sample-bottle.jpg" tppabs="https://ptable.com/wiki/compounds/I/m/Aciphex-sample-bottle.jpg" data-file-width="1137" data-file-height="2092" data-file-type="bitmap" height="405" width="220"><div class="thumbcaption" style="text-align: left">Bottle of rabeprazole 20 mg tablets.</div></div></div>
<p>Rabeprazole, like other proton pump inhibitors such as <a href="Omeprazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Omeprazole" title="Omeprazole">omeprazole</a>, is used for the purposes of gastric acid suppression.<span class="mw-ref" id="cite_ref-Dadabhai_review_13-0"><a href="#cite_note-Dadabhai_review-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span> This effect is beneficial for the treatment and prevention of conditions in which gastric acid directly worsens symptoms, such as duodenal and gastric ulcers.<span class="mw-ref" id="cite_ref-Dadabhai_review_13-1"><a href="#cite_note-Dadabhai_review-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span> In the setting of gastroesophageal reflux disease (GERD), whose pathophysiology is characterized by prolonged exposure to gastric acid in the esophagus (often due to changes in stomach and/or esophagus anatomy, such as those induced by abdominal obesity),<span class="mw-ref" id="cite_ref-Change_et_al_obesity_gerd_14-0"><a href="#cite_note-Change_et_al_obesity_gerd-14" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span> acid suppression can provide symptomatic relief.<span class="mw-ref" id="cite_ref-Dadabhai_review_13-2"><a href="#cite_note-Dadabhai_review-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span> Acid suppression is also useful when gastric production of acid is increased, including conditions with excess gastric acid secretion (hypersecretory conditions) like Zollinger-Ellison syndrome, multiple endocrine adenomas, and systemic mastocytosis.<span class="mw-ref" id="cite_ref-Dadabhai_review_13-3"><a href="#cite_note-Dadabhai_review-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span></p>

<p>Rabeprazole is also useful alongside antibiotic therapy for the treatment of the pathogen <i>Helicobacter pylori</i>, which otherwise thrives in acidic environments.<span class="mw-ref" id="cite_ref-Dadabhai_review_13-4"><a href="#cite_note-Dadabhai_review-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span> Notably, <i>H. pylori</i> eradication with antibiotics and rabeprazole was also shown to prevent development of second gastric cancer in a randomized trial in high-risk South Korean patients with early stomach cancer treated by endoscopy.<span class="mw-ref" id="cite_ref-pmid29562147_15-0"><a href="#cite_note-pmid29562147-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span></p>

<p>Thus, rabeprazole is US Food and Drug Administration (FDA) approved for the treatment of symptomatic GERD in adolescents and adults, healing duodenal ulcers in adults, eradication of <i>Helicobacter pylori</i>, and pathologic hypersecretory conditions.<span class="mw-ref" id="cite_ref-AHFS2019_6-6"><a href="#cite_note-AHFS2019-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span></p>


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Available_forms">Available forms</h3></summary>
    
<p>The only available formulation of rabeprazole is in 20<span>&nbsp;</span>mg, delayed-release tablets (pictured below).<span class="mw-ref" id="cite_ref-AHFS2019_6-7"><a href="#cite_note-AHFS2019-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span> Rabeprazole-based products, like other proton pump inhibitor products, have to be formulated in delayed-release tablets to protect the active medication from being degraded by the acid of the stomach before being absorbed.<span class="mw-ref" id="cite_ref-Marelli_Review_2012_2-5"><a href="#cite_note-Marelli_Review_2012-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Specific_populations">Specific populations</h3></summary>
    

</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="Pediatrics">Pediatrics</h4></summary>
    
<p>Rabeprazole's only pediatric indication is for the treatment of symptomatic GERD in adolescents (12 years-old and up).<span class="mw-ref" id="cite_ref-AHFS2019_6-8"><a href="#cite_note-AHFS2019-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span></p>


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="Pregnancy">Pregnancy</h4></summary>
    
<p>Studies using animals models to investigate the likelihood for rabeprazole to cause harm to fetuses have not yet shown evidence of harm, though avoidance of rabeprazole during pregnancy (especially during the critical development period of the first trimester) is considered to be the safest possible route until human studies clarify the exact risk.<span class="mw-ref" id="cite_ref-Dadabhai_review_13-5"><a href="#cite_note-Dadabhai_review-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span></p>


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="Lactation">Lactation</h4></summary>
    
<p>It is expected that rabeprazole will be secreted into human breast milk, though the clinical impact of this is still unknown. Avoiding rabeprazole during breastfeeding confers to lowest possible risk.<span class="mw-ref" id="cite_ref-Dadabhai_review_13-6"><a href="#cite_note-Dadabhai_review-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span></p>


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="Geriatrics">Geriatrics</h4></summary>
    
<p>Advanced age does not appear to clinically impact rabeprazole's metabolism.<span class="mw-ref" id="cite_ref-Langtry_Review_3-2"><a href="#cite_note-Langtry_Review-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span> However, elevations in the maximum plasma concentration and the total drug exposure (area under the curve, AUC) have occurred.<span class="mw-ref" id="cite_ref-Dadabhai_review_13-7"><a href="#cite_note-Dadabhai_review-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span></p>


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="Japanese_ancestry">Japanese ancestry</h4></summary>
    
<p>In a study on rabeprazole's pharmacokinetics, the AUC was elevated by approximately 50–60% in men of Japanese ancestry compared to men in the United States.<span class="mw-ref" id="cite_ref-Rabeprazole_Drug_Approval_16-0"><a href="#cite_note-Rabeprazole_Drug_Approval-16" style="counter-reset: mw-Ref 16;"><span class="mw-reflink-text">[16]</span></a></span> See the <a href="#Pharmacogenetics" title="Rabeprazole">pharmacogenetics section</a> below for a pharmacogenetic explanation of these findings.</p>


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="Kidney_or_liver_problems">Kidney or liver problems</h4></summary>
    
<p>In people that have kidney or liver problems, these problems do not appear to affect rabeprazole's metabolism in a clinically meaningful way. This includes individuals on dialysis for kidney problems. Severe liver problems like cirrhosis of the liver do affect rabeprazole's elimination half-life, but not to a degree of dangerous accumulation.<span class="mw-ref" id="cite_ref-Langtry_Review_3-3"><a href="#cite_note-Langtry_Review-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span> In a review of patients taking rabeprazole while having end-stage kidney disease and mild-to-moderate severity, chronic compensated cirrhosis of the liver, the alteration in rabeprazole's metabolism was not clinically meaningful.<span class="mw-ref" id="cite_ref-Marelli_Review_2012_2-6"><a href="#cite_note-Marelli_Review_2012-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Contraindications">Contraindications</h2></summary>
    
<p>Rabeprazole is contraindicated in the following populations and situations:<span class="mw-ref" id="cite_ref-AHFS2019_6-9"><a href="#cite_note-AHFS2019-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span></p>
<ul><li>people with a known hypersensitivity to rabeprazole, substituted <a href="Benzimidazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Benzimidazoles" title="Benzimidazoles" class="mw-redirect">benzimidazoles</a> (which are chemically similar to rabeprazole, like <a href="Omeprazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Omeprazole" title="Omeprazole">omeprazole</a>), or any other component of the capsule formulation (e.g. certain dyes)</li>
<li>concurrent use of rilpivirine, a medication used to treat HIV infection</li></ul>


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Hypersensitivity">Hypersensitivity</h3></summary>
    

</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="Syndrome">Syndrome</h4></summary>
    
<p>An allergy to a PPI like rabeprazole may take the form of type I hypersensitivity or delayed hypersensitivity reactions. A selective (pattern C—see below for a discussion of cross-reactivity patterns) type I hypersensitivity reaction to rabeprazole resulting in anaphylaxis has been reported, as well as several whole group hypersentivities.<span class="mw-ref" id="cite_ref-Lombardo_and_Bonadonna_17-0"><a href="#cite_note-Lombardo_and_Bonadonna-17" style="counter-reset: mw-Ref 17;"><span class="mw-reflink-text">[17]</span></a></span></p>


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="Cross-reactivity">Cross-reactivity</h4></summary>
    
<p>Hypersensitivity to PPIs can take the form of whole group hypersensitivity, pattern A, B, or C. Whole group hypersentivity occurs when a person is cross-reactive to all PPIs; that is, all PPIs will induce the allergy. In pattern A, a person may be allergic to <a href="Omeprazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Omeprazole" title="Omeprazole">omeprazole</a>, <a href="Esomeprazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Esomeprazole" title="Esomeprazole">esomeprazole</a>, and <a href="Pantoprazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Pantoprazole" title="Pantoprazole">pantoprazole</a>, but not to <a href="Lansoprazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Lansoprazole" title="Lansoprazole">lansoprazole</a> and rabeprazole. This is thought to be due to the structural similarities between omeprazole, esomeprazole, and pantoprazole, contrasted with lansoprazole and rabeprazole. Pattern B is the opposite, reflecting people that are allergic to lansoprazole and rabeprazole, but not to omeprazole, esomeprazole, and pantoprazole. Pattern C, in the context of rabeprazole, would reflect a person that is allergic to only rabeprazole, but not to other PPIs (omeprazole, esomeprazole, pantoprazole, and lansoprazole).<span class="mw-ref" id="cite_ref-Lombardo_and_Bonadonna_17-1"><a href="#cite_note-Lombardo_and_Bonadonna-17" style="counter-reset: mw-Ref 17;"><span class="mw-reflink-text">[17]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Rilpivirine">Rilpivirine</h3></summary>
    
<p>Rilpivirine, a non-nucleoside reverse transcriptase inhibitor used in the treatment of HIV, is contraindicated with all PPIs because of their acid-suppressing effect. PPIs suppress acid, thereby raising the pH of (alkalizing) the stomach's contents. Rilpivirine is best absorbed under acidic conditions. Therefore, rabeprazole would be expected to decrease the absorption of rilpivirine, decrease the concentration of rilpivirine in the blood, and possibly lead to therapeutic failure and resistance to the medication/class.<span class="mw-ref" id="cite_ref-Edurant_PI_18-0"><a href="#cite_note-Edurant_PI-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Adverse_effects">Adverse effects</h2></summary>
    
<p>In general, rabeprazole is fairly well tolerated, even up to five years after clinical trial follow-up.<span class="mw-ref" id="cite_ref-Marelli_Review_2012_2-7"><a href="#cite_note-Marelli_Review_2012-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> The side effect profile is similar to that of <a href="Omeprazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Omeprazole" title="Omeprazole">omeprazole</a>.<span class="mw-ref" id="cite_ref-Langtry_Review_3-4"><a href="#cite_note-Langtry_Review-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span> The most common side effects include headache, nausea, and diarrhea.<span class="mw-ref" id="cite_ref-Marelli_Review_2012_2-8"><a href="#cite_note-Marelli_Review_2012-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> Rare side effects include rashes, flu-like symptoms, and infections (including by the gastrointestinal pathogen <i>Clostridium difficile</i><span class="mw-ref" id="cite_ref-Aciphex_Package_Insert_19-0"><a href="#cite_note-Aciphex_Package_Insert-19" style="counter-reset: mw-Ref 19;"><span class="mw-reflink-text">[19]</span></a></span>).<span class="mw-ref" id="cite_ref-Langtry_Review_3-5"><a href="#cite_note-Langtry_Review-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span> Rare instances of rabeprazole-induced liver injury (also known as hepatotoxicity) have been reported. Characteristic proton-pump inhibitor hepatoxicity usually occurs within the first four weeks of starting the medication.<span class="mw-ref" id="cite_ref-Livertox_Rabeprazole_20-0"><a href="#cite_note-Livertox_Rabeprazole-20" style="counter-reset: mw-Ref 20;"><span class="mw-reflink-text">[20]</span></a></span></p>

<p>Rabeprazole is associated with elevated serum gastrin levels, which are thought to be dependent upon the degree of CYP2C19 metabolism the drug undergoes. In comparison, rabeprazole is not as significantly metabolized by this enzyme compared to other medications in the same class, like omeprazole.<span class="mw-ref" id="cite_ref-Marelli_Review_2012_2-9"><a href="#cite_note-Marelli_Review_2012-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> Elevated serum gastrin may be associated with gastric cancer.<span class="mw-ref" id="cite_ref-Ahn_et_al_21-0"><a href="#cite_note-Ahn_et_al-21" style="counter-reset: mw-Ref 21;"><span class="mw-reflink-text">[21]</span></a></span></p>

<p>Acid suppression via rabeprazole can decrease the absorption of <a href="Vitamin_B12.htm" tppabs="https://ptable.com/wiki/compounds/A/Vitamin_B12" title="Vitamin B12">vitamin B12</a> and <a href="Magnesium.htm" tppabs="https://ptable.com/wiki/compounds/A/Magnesium" title="Magnesium">magnesium</a>, leading to deficiency.<span class="mw-ref" id="cite_ref-AHFS2019_6-10"><a href="#cite_note-AHFS2019-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span></p>

<p>Very serious side effects have been reported in people taking rabeprazole, but these effects have not been "correlated directly" with the use of rabeprazole.<span class="mw-ref" id="cite_ref-Dadabhai_review_13-8"><a href="#cite_note-Dadabhai_review-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span> These include Stevens–Johnson syndrome, serious hematological abnormalities, coma, and death.<span class="mw-ref" id="cite_ref-Dadabhai_review_13-9"><a href="#cite_note-Dadabhai_review-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span> Other possible side effects, common to other PPIs medications in the same class, include bone fractures due to osteoporosis and serious infections with <i>Clostridium difficile</i>.<span class="mw-ref" id="cite_ref-AHFS2019_6-11"><a href="#cite_note-AHFS2019-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Overdose">Overdose</h2></summary>
    
<p>No signs and symptoms have been reported in overdoses of rabeprazole up to 80<span>&nbsp;</span>mg, but case examples are limited.<span class="mw-ref" id="cite_ref-NLM_Toxnet_Rabeprazole_22-0"><a href="#cite_note-NLM_Toxnet_Rabeprazole-22" style="counter-reset: mw-Ref 22;"><span class="mw-reflink-text">[22]</span></a></span> Notably, rabeprazole has been used in higher doses for the treatment of hypersecretory conditions like Zollinger-Ellison syndrome (up to 120<span>&nbsp;</span>mg daily).<span class="mw-ref" id="cite_ref-NLM_Toxnet_Rabeprazole_22-1"><a href="#cite_note-NLM_Toxnet_Rabeprazole-22" style="counter-reset: mw-Ref 22;"><span class="mw-reflink-text">[22]</span></a></span></p>

<p>Animal experiments with ultra-high doses of rabeprazole have demonstrated lethality through unknown mechanisms. The lethal overdose syndrome in animals is characterized by convulsion and coma.<span class="mw-ref" id="cite_ref-Rabeprazole_Drug_Approval_16-1"><a href="#cite_note-Rabeprazole_Drug_Approval-16" style="counter-reset: mw-Ref 16;"><span class="mw-reflink-text">[16]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Interactions">Interactions</h2></summary>
    

    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Drug-drug_interactions">Drug-drug interactions</h3></summary>
    
<p>Rabeprazole does not interfere with the plasma concentration of drugs that are also metabolized by the same enzymes (i.e. CYP2C19) that it is metabolized by. Therefore, it is not expected to react with CYP2C19 substrates like <a href="Theophylline.htm" tppabs="https://ptable.com/wiki/compounds/A/Theophylline" title="Theophylline">theophylline</a>, <a href="Warfarin.htm" tppabs="https://ptable.com/wiki/compounds/A/Warfarin" title="Warfarin">warfarin</a>, <a href="Diazepam.htm" tppabs="https://ptable.com/wiki/compounds/A/Diazepam" title="Diazepam">diazepam</a>, and <a href="Phenytoin.htm" tppabs="https://ptable.com/wiki/compounds/A/Phenytoin" title="Phenytoin">phenytoin</a>.<span class="mw-ref" id="cite_ref-Langtry_Review_3-6"><a href="#cite_note-Langtry_Review-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span>  However, the acid-suppression effects of rabeprazole, like other PPIs, may interfere with the absorption of drugs that require acid, such as <a href="Ketoconazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Ketoconazole" title="Ketoconazole">ketoconazole</a> and <a href="Digoxin.htm" tppabs="https://ptable.com/wiki/compounds/A/Digoxin" title="Digoxin">digoxin</a>.<span class="mw-ref" id="cite_ref-Dadabhai_review_13-10"><a href="#cite_note-Dadabhai_review-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span></p>

<p>There is some evidence that <a href="Omeprazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Omeprazole" title="Omeprazole">omeprazole</a> and <a href="Esomeprazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Esomeprazole" title="Esomeprazole">esomeprazole</a>, two medications in the same class as rabeprazole, can disturb the conversion of an anticoagulant medication called <a href="Clopidogrel.htm" tppabs="https://ptable.com/wiki/compounds/A/Clopidogrel" title="Clopidogrel">clopidogrel</a> to its active metabolite. However, because this is thought to be mediated by the effect of omeprazole and esomeprazole on CYP2C19, the enzyme that activates clopidogrel, this drug interaction is not expected to occur as strongly with rabeprazole. However, whether the effect of omeprazole and esomeprazole on clopidogrel's metabolism actually leads to poor clinical outcomes is still a matter of intense debate among healthcare professionals.<span class="mw-ref" id="cite_ref-Marelli_Review_2012_2-10"><a href="#cite_note-Marelli_Review_2012-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></p>

<p>Clinically serious drug-drug interactions may involve the acid-suppression effects of rabeprazole. For example, rabeprazole should not be used concomitantly with rilpivirine, an anti-HIV therapy, which requires acid for absorption. Lowered plasma concentrations of rilpivirine could lead to progression of HIV infection. Other drugs that require acid for absorption include antifungal drugs like ketoconazole and <a href="Itraconazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Itraconazole" title="Itraconazole">itraconazole</a>, digoxin, <a href="Iron.htm" tppabs="https://ptable.com/wiki/compounds/A/Iron" title="Iron">iron</a>, <a href="Mycophenolic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Mycophenolate" title="Mycophenolate" class="mw-redirect">mycophenolate</a>, and tyrosine kinase inhibitors like <a href="Erlotinib.htm" tppabs="https://ptable.com/wiki/compounds/A/Erlotinib" title="Erlotinib">erlotinib</a>, <a href="Dasatinib.htm" tppabs="https://ptable.com/wiki/compounds/A/Dasatinib" title="Dasatinib">dasatinib</a>, and nilotinib.<span class="mw-ref" id="cite_ref-AHFS2019_6-12"><a href="#cite_note-AHFS2019-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span> There is no clinically relevant drug interaction between rabeprazole and antacids.<span class="mw-ref" id="cite_ref-Marelli_Review_2012_2-11"><a href="#cite_note-Marelli_Review_2012-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span><span class="mw-ref" id="cite_ref-Rabeprazole_Drug_Approval_16-2"><a href="#cite_note-Rabeprazole_Drug_Approval-16" style="counter-reset: mw-Ref 16;"><span class="mw-reflink-text">[16]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Food-drug_interactions">Food-drug interactions</h3></summary>
    
<p>Food does not affect the amount of rabeprazole that enters the body,<span class="mw-ref" id="cite_ref-Marelli_Review_2012_2-12"><a href="#cite_note-Marelli_Review_2012-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> but it does delay its onset of effect by about 1.7 hours.<span class="mw-ref" id="cite_ref-Langtry_Review_3-7"><a href="#cite_note-Langtry_Review-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Pharmacology">Pharmacology</h2></summary>
    

    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Mechanism_of_action">Mechanism of action</h3></summary>
    
<p>Rabeprazole's mechanism of action first involves getting absorbed into the parietal cells of the stomach, which are the cells that are responsible for secreting <a href="Hydrochloric_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Hydrochloric_acid" title="Hydrochloric acid">hydrochloric acid</a> (HCl).<span class="mw-ref" id="cite_ref-Dadabhai_review_13-11"><a href="#cite_note-Dadabhai_review-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span> At this point, rabeprazole is inactive.<span class="mw-ref" id="cite_ref-Dadabhai_review_13-12"><a href="#cite_note-Dadabhai_review-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span> However, rabeprazole is then secreted into the secretory canaliculus of the parietal cells, which is the space from which acid secretion occurs.<span class="mw-ref" id="cite_ref-Dadabhai_review_13-13"><a href="#cite_note-Dadabhai_review-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span> Here, acid secretion is mediated by the energy-dependent acid pumps, called hydrogen potassium adenosine triphosphatase (H<sup>+</sup>/K<sup>+</sup> ATPase) pumps.<span class="mw-ref" id="cite_ref-Dadabhai_review_13-14"><a href="#cite_note-Dadabhai_review-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span> These enzymatic pumps have <a href="Cysteine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cysteine" title="Cysteine">cysteine</a> amino acid residues.<span class="mw-ref" id="cite_ref-Dadabhai_review_13-15"><a href="#cite_note-Dadabhai_review-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span> After being activated by gastric (stomach) acid to a reactive sulfenamide intermediate,<span class="mw-ref" id="cite_ref-Olbe_Pibrant_p161_23-0"><a href="#cite_note-Olbe_Pibrant_p161-23" style="counter-reset: mw-Ref 23;"><span class="mw-reflink-text">[23]</span></a></span> rabeprazole permanently binds the cysteine residues, forming covalent, disulfide bonds.<span class="mw-ref" id="cite_ref-Dadabhai_review_13-16"><a href="#cite_note-Dadabhai_review-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span> This action fundamentally alters the configuration of the acid pump, thereby inhibiting its activity. Thus, acid can no longer be secreted into the gastric lumen (the empty space of the stomach), and the pH of the stomach increases (decrease in the concentration of hydrogen ions, H<sup>+</sup>).<span class="mw-ref" id="cite_ref-Dadabhai_review_13-17"><a href="#cite_note-Dadabhai_review-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span> Due to the permanent inhibition of the individual proton pump that each molecule of rabeprazole has bound to, acid secretion is effectively suppressed until new proton pumps are produced by the parietal cells.<span class="mw-ref" id="cite_ref-Livertox_Rabeprazole_20-1"><a href="#cite_note-Livertox_Rabeprazole-20" style="counter-reset: mw-Ref 20;"><span class="mw-reflink-text">[20]</span></a></span></p>

<p>Rabeprazole, like other medications in the same class, cannot inhibit the H<sup>+</sup>/K<sup>+</sup> ATPase pumps found in lysosomes, a cellular organelle that degrades biological molecules, because the pumps found in these organelles lack the cysteine residues involved in rabeprazole's mechanism of action.<span class="mw-ref" id="cite_ref-Marelli_Review_2012_2-13"><a href="#cite_note-Marelli_Review_2012-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></p>

<p>A unique feature of rabeprazole's mechanism of action in inhibiting acid secretion involves its activation. The pKa (the pH at which 50% of the drug becomes positively charged) of rabeprazole is around 5.0, meaning that it doesn't take a lot of acid to activate it. While this theoretically translates into a faster onset of action for rabeprazole's acid-inhibiting effect, the clinical implications of this fact have yet to be elucidated.<span class="mw-ref" id="cite_ref-Dadabhai_review_13-18"><a href="#cite_note-Dadabhai_review-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Pharmacokinetics">Pharmacokinetics</h3></summary>
    
<p>Rabeprazole's bioavailability is approximately 52%, meaning that 52% of orally administered dose is expected to enter systemic circulation (the bloodstream).<span class="mw-ref" id="cite_ref-Dadabhai_review_13-19"><a href="#cite_note-Dadabhai_review-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span> Once in the blood, rabeprazole is approximately 96.3%<span class="mw-ref" id="cite_ref-Langtry_Review_3-8"><a href="#cite_note-Langtry_Review-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span>-97%<span class="mw-ref" id="cite_ref-Marelli_Review_2012_2-14"><a href="#cite_note-Marelli_Review_2012-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> bound to plasma proteins. The biological half-life of rabeprazole in humans is approximately one hour.<span class="mw-ref" id="cite_ref-Marelli_Review_2012_2-15"><a href="#cite_note-Marelli_Review_2012-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> It takes about 3.5 hours for rabeprazole to reach the maximum concentration in human plasma after a single orally administered dose. Oral absorption is independent of the dose administered.<span class="mw-ref" id="cite_ref-Marelli_Review_2012_2-16"><a href="#cite_note-Marelli_Review_2012-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></p>

<p>Rabeprazole is extensively metabolized by the liver.<span class="mw-ref" id="cite_ref-Langtry_Review_3-9"><a href="#cite_note-Langtry_Review-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span> 90% of the drug is rendered into metabolites by the liver, which are then excreted by the kidneys.<span class="mw-ref" id="cite_ref-PubChem_4-1"><a href="#cite_note-PubChem-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> 10% of the dose is excreted in the feces.<span class="mw-ref" id="cite_ref-Marelli_Review_2012_2-17"><a href="#cite_note-Marelli_Review_2012-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> The drug metabolizing enzymes primarily responsible for rabeprazole's metabolism are CYP2C19 and CYP3A4.<span class="mw-ref" id="cite_ref-Langtry_Review_3-10"><a href="#cite_note-Langtry_Review-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span> However, rabeprazole is mainly metabolized through non-enzymatic reduction to a thioether metabolite.<span class="mw-ref" id="cite_ref-Marelli_Review_2012_2-18"><a href="#cite_note-Marelli_Review_2012-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> Some of rabeprazole's metabolites include the following: a thioether carboxylic acid metabolite, a thioether glucuronide metabolite, and a sulfone metabolite.<span class="mw-ref" id="cite_ref-Langtry_Review_3-11"><a href="#cite_note-Langtry_Review-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span> The most common metabolites excreted in the urine are the mercapturic acid conjugate and carboxylic acid.<span class="mw-ref" id="cite_ref-Marelli_Review_2012_2-19"><a href="#cite_note-Marelli_Review_2012-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> A diagram of rabeprazole's phase I metabolism is shown below.<span class="mw-ref" id="cite_ref-Rabeprazole_Drug_Approval_16-3"><a href="#cite_note-Rabeprazole_Drug_Approval-16" style="counter-reset: mw-Ref 16;"><span class="mw-reflink-text">[16]</span></a></span></p>

<center><div class="thumb tnone"></div><div class="thumbinner" style="width:802px"><img src="../I/m/Metabolism_of_rabeprazole.jpg" tppabs="https://ptable.com/wiki/compounds/I/m/Metabolism_of_rabeprazole.jpg" data-file-width="905" data-file-height="646" data-file-type="bitmap" height="571" width="800"><div class="thumbcaption" style="text-align: left">Phase I metabolism of rabeprazole,<span class="mw-ref" id="cite_ref-Rabeprazole_Drug_Approval_16-4"><a href="#cite_note-Rabeprazole_Drug_Approval-16" style="counter-reset: mw-Ref 16;"><span class="mw-reflink-text">[16]</span></a></span> drawn in ChemSketch.</div></div></center>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Pharmacogenetics">Pharmacogenetics</h3></summary>
    
<p>The effect of rabeprazole may vary based upon the genetics of the individual taking the medication. People may have differences in their capacity to metabolize rabeprazole to an inactive metabolite. This may be mediated through genetic differences in the gene that encodes for the metabolic enzyme CYP2C19. For example, people that are poor CYP2C19 metabolizers (i.e. their version of CYP2C19 is less effective than average) will have trouble metabolizing rabeprazole, allowing the active rabeprazole to stay in the body, where it can exert its effect, longer than intended. Conversely, extensive CYP2C19 metabolizers (i.e. the average metabolic capacity of CYP2C19) will extensively metabolize rabeprazole, as expected. The poor metabolizing CYP2C19 phenotype is found in roughly 3–5% of Caucasian people, and in 17–20% of people of Asian ancestry.<span class="mw-ref" id="cite_ref-PharmGKB_Label_for_Rab_24-0"><a href="#cite_note-PharmGKB_Label_for_Rab-24" style="counter-reset: mw-Ref 24;"><span class="mw-reflink-text">[24]</span></a></span> In a study on men of Japanese ancestry, this has translated to an average increase of total drug exposure by 50–60% compared to men in the United States.<span class="mw-ref" id="cite_ref-Rabeprazole_Drug_Approval_16-5"><a href="#cite_note-Rabeprazole_Drug_Approval-16" style="counter-reset: mw-Ref 16;"><span class="mw-reflink-text">[16]</span></a></span></p>

<p>However, rabeprazole's metabolism is primarily non-enzymatic (it is often inactivated chemically, without the participation of the body's natural drug metabolizing enzymes). Therefore, while a person's CYP2C19 phenotype will affect rabeprazole's metabolism, it is not expected to dramatically affect the efficacy of the medication.<span class="mw-ref" id="cite_ref-Marelli_Review_2012_2-20"><a href="#cite_note-Marelli_Review_2012-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Chemistry">Chemistry</h2></summary>
    
<div class="thumb tright"><div class="thumbinner" style="width:222px"><img src="../I/m/Rabeprazolespin.gif" tppabs="https://ptable.com/wiki/compounds/I/m/Rabeprazolespin.gif" data-file-width="455" data-file-height="249" data-file-type="bitmap" height="120" width="220"><div class="thumbcaption" style="text-align: left">3D representation of rabeprazole spinning along an axis.</div></div></div>
<p>Rabeprazole is classified as a substituted <a href="Benzimidazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Benzimidazole" title="Benzimidazole">benzimidazole</a>, like <a href="Omeprazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Omeprazole" title="Omeprazole">omeprazole</a>, <a href="Lansoprazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Lansoprazole" title="Lansoprazole">lansoprazole</a>, and <a href="Pantoprazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Pantoprazole" title="Pantoprazole">pantoprazole</a>.<span class="mw-ref" id="cite_ref-Olbe_Pibrant_p161_23-1"><a href="#cite_note-Olbe_Pibrant_p161-23" style="counter-reset: mw-Ref 23;"><span class="mw-reflink-text">[23]</span></a></span> Rabeprazole possess properties of both acids and bases, making it an amphotere.<span class="mw-ref" id="cite_ref-Olbe_Pibrant_p161_23-2"><a href="#cite_note-Olbe_Pibrant_p161-23" style="counter-reset: mw-Ref 23;"><span class="mw-reflink-text">[23]</span></a></span> The acid dissociation constant (pK<sub>a</sub>) of the <a href="Pyridine.htm" tppabs="https://ptable.com/wiki/compounds/A/Pyridine" title="Pyridine">pyridine</a> <a href="Nitrogen.htm" tppabs="https://ptable.com/wiki/compounds/A/Nitrogen" title="Nitrogen">nitrogen</a> is about equal to 5.<span class="mw-ref" id="cite_ref-Olbe_Pibrant_p161_23-3"><a href="#cite_note-Olbe_Pibrant_p161-23" style="counter-reset: mw-Ref 23;"><span class="mw-reflink-text">[23]</span></a></span></p>


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Synthesis">Synthesis</h3></summary>
    
<center><div class="thumb tnone"></div><div class="thumbinner" style="width:802px"><img src="../I/m/Rabeprazole_synthesis.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Rabeprazole_synthesis.svg.png" data-file-width="512" data-file-height="116" data-file-type="drawing" height="181" width="800"><div class="thumbcaption" style="text-align: left">Rabeprazole synthesis diagram.<span class="mw-ref" id="cite_ref-Synth1_25-0"><a href="#cite_note-Synth1-25" style="counter-reset: mw-Ref 25;"><span class="mw-reflink-text">[25]</span></a></span><span class="mw-ref" id="cite_ref-Synth2_26-0"><a href="#cite_note-Synth2-26" style="counter-reset: mw-Ref 26;"><span class="mw-reflink-text">[26]</span></a></span></div></div></center>
<p>The above synthesis pathway begins with 2,3-dimethypyridine <i>N</i>-oxide (<b>1</b>). Nitration of 2,3-dimethylpyridine <i>N</i>-oxide affords the nitro derivative (the addition of <a href="Nitrogen_dioxide.htm" tppabs="https://ptable.com/wiki/compounds/A/NO2" title="NO2" class="mw-redirect">NO<sub>2</sub></a>) (<b>2</b>) The newly introduced nitro group is then displaced by the alkoxide from 3-methoxypropanol to yield the corresponding ether (<b>3</b>). Treatment with <a href="Acetic_anhydride.htm" tppabs="https://ptable.com/wiki/compounds/A/Acetic_anhydride" title="Acetic anhydride">acetic anhydride</a> results in the Polonovski reaction. Saponification followed by treatment with <a href="Thionyl_chloride.htm" tppabs="https://ptable.com/wiki/compounds/A/Thionyl_chloride" title="Thionyl chloride">thionyl chloride</a> then chlorinates the primary alcohol (<b>5</b>). Reaction with benzimidazole-2-thiol (<b>6</b>) followed by oxidation of the resulting thioether to the <a href="Sulfoxide.htm" tppabs="https://ptable.com/wiki/compounds/A/Sulfoxide" title="Sulfoxide">sulfoxide</a> yields the final product: rabeprazole (<b>8</b>).<span class="mw-ref" id="cite_ref-Synth1_25-1"><a href="#cite_note-Synth1-25" style="counter-reset: mw-Ref 25;"><span class="mw-reflink-text">[25]</span></a></span><span class="mw-ref" id="cite_ref-Synth2_26-1"><a href="#cite_note-Synth2-26" style="counter-reset: mw-Ref 26;"><span class="mw-reflink-text">[26]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Physiochemical_properties">Physiochemical properties</h3></summary>
    
<p>Rabeprazole is characterized as a white to yellowish-white solid in its pure form. It is soluble in a number of solvents. Rabeprazole is very soluble in water and <a href="Methanol.htm" tppabs="https://ptable.com/wiki/compounds/A/Methanol" title="Methanol">methanol</a>, freely soluble in <a href="Ethanol.htm" tppabs="https://ptable.com/wiki/compounds/A/Ethanol" title="Ethanol">ethanol</a>, <a href="Chloroform.htm" tppabs="https://ptable.com/wiki/compounds/A/Chloroform" title="Chloroform">chloroform</a>, and <a href="Ethyl_acetate.htm" tppabs="https://ptable.com/wiki/compounds/A/Ethyl_acetate" title="Ethyl acetate">ethyl acetate</a>, and is insoluble in <a href="Diethyl_ether.htm" tppabs="https://ptable.com/wiki/compounds/A/Diethyl_ether" title="Diethyl ether">ether</a> and <a href="Hexane.htm" tppabs="https://ptable.com/wiki/compounds/A/N-hexane" title="N-hexane" class="mw-redirect">n-hexane</a>.<span class="mw-ref" id="cite_ref-Rabeprazole_Drug_Approval_16-6"><a href="#cite_note-Rabeprazole_Drug_Approval-16" style="counter-reset: mw-Ref 16;"><span class="mw-reflink-text">[16]</span></a></span> It is unstable under humid conditions.<span class="mw-ref" id="cite_ref-Marelli_Review_2012_2-21"><a href="#cite_note-Marelli_Review_2012-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="History">History</h2></summary>
    
<p>Rabeprazole was first marketed in Europe in 1998.<span class="mw-ref" id="cite_ref-Marelli_Review_2012_2-22"><a href="#cite_note-Marelli_Review_2012-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> In 1999, one year later, rabeprazole was approved for use in the United States.<span class="mw-ref" id="cite_ref-Aciphex_Package_Insert_19-1"><a href="#cite_note-Aciphex_Package_Insert-19" style="counter-reset: mw-Ref 19;"><span class="mw-reflink-text">[19]</span></a></span></p>


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Development">Development</h3></summary>
    
<p>Developed by Eisai Medical Research by the research names E3810 and LY307640, the pre-investigational new drug application was submitted on October 28, 1998. The final investigational new drug application was submitted August 6, 1999. On August 19, 1999, rabeprazole was approved in the US for multiple gastrointestinal indications. The approval for the treatment of symptomatic gastroesophageal reflux disease was on February 12, 2002.<span class="mw-ref" id="cite_ref-StatReview_1_27-0"><a href="#cite_note-StatReview_1-27" style="counter-reset: mw-Ref 27;"><span class="mw-reflink-text">[27]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Society_and_culture">Society and culture</h2></summary>
    

    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Legal_status">Legal status</h3></summary>
    
<p>Rabeprazole is approved in the United States<span class="mw-ref" id="cite_ref-FDA_approval_label_for_generic_28-0"><a href="#cite_note-FDA_approval_label_for_generic-28" style="counter-reset: mw-Ref 28;"><span class="mw-reflink-text">[28]</span></a></span> and the United Kingdom<span class="mw-ref" id="cite_ref-UK_label_for_generic_29-0"><a href="#cite_note-UK_label_for_generic-29" style="counter-reset: mw-Ref 29;"><span class="mw-reflink-text">[29]</span></a></span> for prescription use only. Rabeprazole was approved in India in December 2001.<span class="mw-ref" id="cite_ref-Indian_Approvals_30-0"><a href="#cite_note-Indian_Approvals-30" style="counter-reset: mw-Ref 30;"><span class="mw-reflink-text">[30]</span></a></span> It was approved in Japan in 1997, and in all European Union member countries since.<span class="mw-ref" id="cite_ref-Aciphex_Press_Release_31-0"><a href="#cite_note-Aciphex_Press_Release-31" style="counter-reset: mw-Ref 31;"><span class="mw-reflink-text">[31]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Brand_names">Brand names</h3></summary>
    
<p>Rabeprazole has been sold in a number of brand names:<span class="mw-ref" id="cite_ref-brands_32-0"><a href="#cite_note-brands-32" style="counter-reset: mw-Ref 32;"><span class="mw-reflink-text">[32]</span></a></span></p>

<table class="wikitable mw-collapsible mw-collapsed" style="width:100%">
<caption>List of trade names for rabeprazole<span class="mw-ref" id="cite_ref-brands_32-1"><a href="#cite_note-brands-32" style="counter-reset: mw-Ref 32;"><span class="mw-reflink-text">[32]</span></a></span></caption>
<tbody><tr>
<th scope="col">Alphabet</th>
<th scope="col">Brand Name</th></tr>
<tr>
<td>A</td><td>Acera, Acifix, Acilesol, Aciphex, Acistal, Akirab, Algibra, An Si Fei, Anslag, Antuc, Apt, Aurizol-R</td></tr>
<tr class="mw-empty-elt"></tr>
<tr>
<td>B</td><td>Bacanero, Barole, Bauzole, Bepra, Bepraz, Berazol, Berizar, Beryx</td></tr>
<tr>
<td>C</td><td>Cyra</td></tr>
<tr>
<td>D</td><td>Dexicool, Dexpure, Dirab, Domol</td></tr>
<tr>
<td>E</td><td>Eurorapi</td></tr>
<tr>
<td>F</td><td>Finix, Fodren</td></tr>
<tr>
<td>G</td><td>Gastech, Gastrazole, Gastrodine, Gelbra</td></tr>
<tr>
<td>H</td><td>Happi, Helirab, Heptadin</td></tr>
<tr>
<td>I</td><td>Idizole</td></tr>
<tr>
<td>J</td><td>Jelgrad, Ji Nuo</td></tr>
<tr>
<td>K</td><td></td></tr>
<tr>
<td>L</td><td></td></tr>
<tr>
<td>M</td><td>Mergium, Monrab</td></tr>
<tr>
<td>N</td><td>Neutracaine, Newrabell, Noflux</td></tr>
<tr>
<td>O</td><td>Olrite, Ontime, Oppi-R</td></tr>
<tr>
<td>P</td><td>Paliell, Paramet, Paricel, Pariet, Pepcia, Pepraz, Ppbest, Praber, Prabex, Prabexol, Prabez, Promto, Puloros</td></tr>
<tr>
<td>Q</td><td></td></tr>
<tr>
<td>R</td><td>R-Bit, R-Cid, R-PPI, R-Safe, R.P.Zole, Rabby, Rabe, Rabe-G, Rabeact-20, Rabec, Rabeca, Rabecell, Rabecis, Rabecole, Rabecom, Rabecon, Rabee, Rabefine, Rabegen, Rabekind, Rabelex, Rabelinz, Rabelis, Rabeloc, Rabeman, Rabemed, Rabeol, Rabeone, Rabep, Rabepazole, Rabephex, Rabeprazol, Rabeprazole, Rabeprazolo, Rabeprazolum, Rabesec, Rabestad, Rabetac, Rabetome, Rabetra, Rabetune, Rabeum, Rabex, Rabez, Rabez-FR, Rabezol, Rabezole, Rabibit, Rabicent, Rabicid, Rabicip, Rabifar, Rabifast, Rabilect, Rabip, Rabipot, Rabirol, Rabitab, Rabium, Rabiza, Rabizol, Rablet, Rablet-B, Rabon, Raboz, Rabroz, Rabyprex, Ragi, Ralic, Ramprozole, Raneks, Rap, Rapeed, Rapespes, Rapo, Rapoxol, Rasonix, Razid, Razit, Razo, Razodent, Razogard, Rebacip, Redura, Reorab, Reward, Rifcid, Rodesa, Rolant, Roll, Rowet, Rpraz, Rui Bo te, Rulcer</td></tr>
<tr>
<td>S</td><td>Setright, Staycool, Stom, Stomeck</td></tr>
<tr>
<td>T</td><td></td></tr>
<tr>
<td>U</td><td>Ulceprazol, Ulcerostate</td></tr>
<tr>
<td>V</td><td>Value, Veloz</td></tr>
<tr>
<td>W</td><td>Wowrab</td></tr>
<tr>
<td>X</td><td>Xin Wei An</td></tr>
<tr>
<td>Y</td><td>Yu Tian Qing</td></tr>
<tr>
<td>Z</td><td>Zibepar, Zolpras, Zulbex</td></tr>
<tr class="mw-empty-elt"></tr>
</tbody></table>

<table class="wikitable mw-collapsible mw-collapsed" style="width:100%">
<caption>List of trade names for rabeprazole-containing combination products<span class="mw-ref" id="cite_ref-brands_32-2"><a href="#cite_note-brands-32" style="counter-reset: mw-Ref 32;"><span class="mw-reflink-text">[32]</span></a></span></caption>
<tbody><tr>
<th scope="col">Generic Combination</th>
<th scope="col">Brand Name</th></tr>
<tr>
<td>rabeprazole, <a href="Amoxicillin.htm" tppabs="https://ptable.com/wiki/compounds/A/Amoxicillin" title="Amoxicillin">amoxicillin</a>, <a href="Clarithromycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Clarithromycin" title="Clarithromycin">clarithromycin</a></td><td>Rabecure, Pylocure</td></tr>
<tr>
<td>rabeprazole, <a href="Amoxicillin.htm" tppabs="https://ptable.com/wiki/compounds/A/Amoxicillin" title="Amoxicillin">amoxicillin</a>, <a href="Metronidazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Metronidazole" title="Metronidazole">metronidazole</a></td><td>Rabefine</td></tr>
<tr>
<td>rabeprazole, <a href="Diclofenac.htm" tppabs="https://ptable.com/wiki/compounds/A/Diclofenac" title="Diclofenac">diclofenac</a></td><td>Drab, Rabin-DFX, Rclonac, Safediclo, Samurai</td></tr>
<tr>
<td>rabeprazole, <a href="Domperidone.htm" tppabs="https://ptable.com/wiki/compounds/A/Domperidone" title="Domperidone">domperidone</a></td><td>Acera-D, Acistal-D, Adec-R, Algibra-D, Anslag-D, Antuc-DSR, Biorab-DSR, Catrab-DSR, Comvine, Cyclochek, Cyra-D, Dirab-D, Domol-R, Esoga-RD, Gasonil-D, Gastrazole-D, Happi-D, Helirab-D, Kurab-DSR, Lorab-DSR, Neutraflux, Nuloc-D, Olrite-DSR, Parisec-DSR, Pepchek, Pepcia-D, Peraz-D, Ppbest-D, Prazim-RD, Prorab-D, R-Bit-DM, R-Bit-DSR, R-Cid Plus, R-DSR, R-Safe DSR, Rabby-DSR, Rabecis-DSR, Rabecom-D, Rabecon-DSR, Rabee-D, Rabefine-DSR, Rabelex-D, Rabemac-DSR, Rabep-DSR, Rabephex-D, Rabetome-DM, Rabetome-DSR, Rabetune-D, Rabex-D, Rabez-D, Rabi-DSR, Rabibit-D, Rabicent-D, Rabicip-D, Rabifast-DSR, Rabilect-DSR, Rabipot-D, Rabiprime-DSR, Rablet-D, Rabon-D, Rabon-DSR, Rabroz-DSR, Rabter-SR, Raizol-DSR, Rap-D, Rapeed-D, Rapo-DSR, Raz-DSR, Rebilex-DSR, Redoxid, Redura-D, Redura-DSR, Reorab-D, Reorab-DSR, Reward-D, Reward-DSR, Rifcid-D, Rifcid-DSR, Rifkool-DSR, Robilink-D, Rolant-D, Roll-D, Rpraz-D, Rugbi-DM, Rulcer-DSR, Setright-DSR, Sharaz-D, Staycool-DXR, Stomeck-D SR, Ulgo-DSR, Xenorab-DSR, Zolorab-D, Zomitac-DSR, Zorab-D</td></tr>
<tr>
<td>rabeprazole, itopride</td><td>Acera-IT, Antuc-IT, Cool Rab-IT, Happi-IT, Itopraz, Itorab, Jeprab-ITO, Pepraz-I, Rabee-ISR, Rabemac-ITR, Rabetome-ISR, Rabez-IT, Rabibit-ISR, Rablet-I, Rablet-IT, Rebilex-ISR, Reorab-IT, Rex-ISR, Rulcer-IT, Veloz-IT, and Zorite</td></tr>
<tr>
<td>rabeprazole, lafutidine</td><td>Lafumac Plus</td></tr>
<tr>
<td>rabeprazole, <a href="Levosulpiride.htm" tppabs="https://ptable.com/wiki/compounds/A/Levosulpiride" title="Levosulpiride">levosulpiride</a></td><td>Happi-L, Lorab-L, Rabekind Plus, Rabicent-L, Rabifast-XL, Rabin-LXR, Rabinta-L, Rabitem-LS, Robiwel-L, Roll-LS, Wokride</td></tr>
<tr>
<td>rabeprazole, <a href="Ondansetron.htm" tppabs="https://ptable.com/wiki/compounds/A/Ondansetron" title="Ondansetron">ondansetron</a></td><td>Ond-R, Rulcer-ON</td></tr>
<tr>
<td>rabeprazole, polaprezinc</td><td>Happi-XT, Rabez-Z</td></tr>
<tr>
<td>rabeprazole, <a href="Sodium_bicarbonate.htm" tppabs="https://ptable.com/wiki/compounds/A/Sodium_bicarbonate" title="Sodium bicarbonate">sodium bicarbonate</a></td><td>Pepcia-FF, Raizol</td></tr>
</tbody></table>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Research">Research</h2></summary>
    
<p>An alternative formulation of rabeprazole, termed "rabeprazole-ER" (extended release) has been developed. The purpose of the formulation was to increase the half-life of rabeprazole, which normally is very short in humans. Rabeprazole-ER was a 50<span>&nbsp;</span>mg capsule composed of five non-identical 10<span>&nbsp;</span>mg tablets that were designed to release rabeprazole at differing intervals throughout the gastrointestinal system. However, because two high quality clinical trials failed to demonstrate a benefit of rabeprazole-ER versus <a href="Esomeprazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Esomeprazole" title="Esomeprazole">esomeprazole</a> (another common PPI) for healing grade C or D erosive esophagitis, the development of rabeprazole-ER ceased.<span class="mw-ref" id="cite_ref-Strand_et_al_2017_33-0"><a href="#cite_note-Strand_et_al_2017-33" style="counter-reset: mw-Ref 33;"><span class="mw-reflink-text">[33]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="References">References</h2></summary>
    
<div class="reflist " style=" list-style-type: decimal;">
<div class="mw-references-wrap mw-references-columns"><ol class="mw-references references"><li id="cite_note-Drugs.com_pregnancy-1"> <span id="mw-reference-text-cite_note-Drugs.com_pregnancy-1" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.drugs.com/pregnancy/rabeprazole.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/pregnancy/rabeprazole.html'" tppabs="https://www.drugs.com/pregnancy/rabeprazole.html" class="external text external">"Rabeprazole Use During Pregnancy"</a>. <i>Drugs.com</i>. 25 June 2018<span class="reference-accessdate">. Retrieved <span class="nowrap">10 January</span> 2020</span>.</cite></span></li><li id="cite_note-Marelli_Review_2012-2"> <span id="mw-reference-text-cite_note-Marelli_Review_2012-2" class="mw-reference-text"><cite id="CITEREFMarelliPace2014" class="citation journal cs1">Marelli, Silvia; Pace, Fabio (10 January 2014). "Rabeprazole for the treatment of acid-related disorders". <i>Expert Review of Gastroenterology &amp; Hepatology</i>. <b>6</b> (4): 423–435. doi:<a href="javascript:if(confirm('https://doi.org/10.1586%2Fegh.12.18  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1586%2Fegh.12.18'" tppabs="https://doi.org/10.1586%2Fegh.12.18" class="external text external">10.1586/egh.12.18</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/22928894  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/22928894'" tppabs="https://pubmed.ncbi.nlm.nih.gov/22928894" class="external text external">22928894</a>.</cite></span></li><li id="cite_note-Langtry_Review-3"> <span id="mw-reference-text-cite_note-Langtry_Review-3" class="mw-reference-text"><cite id="CITEREFLangtryMarkham1999" class="citation journal cs1">Langtry, HD; Markham, A (October 1999). "Rabeprazole: a review of its use in acid-related gastrointestinal disorders". <i>Drugs</i>. <b>58</b> (4): 725–42. doi:<a href="javascript:if(confirm('https://doi.org/10.2165%2F00003495-199958040-00014  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2165%2F00003495-199958040-00014'" tppabs="https://doi.org/10.2165%2F00003495-199958040-00014" class="external text external">10.2165/00003495-199958040-00014</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/10551440  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/10551440'" tppabs="https://pubmed.ncbi.nlm.nih.gov/10551440" class="external text external">10551440</a>.</cite></span></li><li id="cite_note-PubChem-4"> <span id="mw-reference-text-cite_note-PubChem-4" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://pubchem.ncbi.nlm.nih.gov/compound/rabeprazole  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubchem.ncbi.nlm.nih.gov/compound/rabeprazole#section=Absorption-Distribution-and-Excretion&fullscreen=true'" tppabs="https://pubchem.ncbi.nlm.nih.gov/compound/rabeprazole#section=Absorption-Distribution-and-Excretion&fullscreen=true" class="external text external">"Rabeprazole"</a>. <i>PubChem</i>. NCBI<span class="reference-accessdate">. Retrieved <span class="nowrap">10 January</span> 2020</span>.</cite></span></li><li id="cite_note-5"> <span id="mw-reference-text-cite_note-5" class="mw-reference-text"><cite id="CITEREFPubChem" class="citation web cs1">PubChem. <a href="javascript:if(confirm('https://pubchem.ncbi.nlm.nih.gov/compound/5029  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubchem.ncbi.nlm.nih.gov/compound/5029'" tppabs="https://pubchem.ncbi.nlm.nih.gov/compound/5029" class="external text external">"Rabeprazole"</a>. <i>PubChem</i><span class="reference-accessdate">. Retrieved <span class="nowrap">10 January</span> 2020</span>.</cite></span></li><li id="cite_note-AHFS2019-6"> <span id="mw-reference-text-cite_note-AHFS2019-6" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.drugs.com/monograph/rabeprazole-sodium.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/monograph/rabeprazole-sodium.html'" tppabs="https://www.drugs.com/monograph/rabeprazole-sodium.html" class="external text external">"Rabeprazole Sodium Monograph for Professionals"</a>. <i>Drugs.com</i>. American Society of Health-System Pharmacists<span class="reference-accessdate">. Retrieved <span class="nowrap">3 March</span> 2019</span>.</cite></span></li><li id="cite_note-BNF76-7"> <span id="mw-reference-text-cite_note-BNF76-7" class="mw-reference-text"><cite class="citation book cs1"><i>British national formulary<span>&nbsp;</span>: BNF 76</i> (76 ed.). Pharmaceutical Press. 2018. p.<span>&nbsp;</span>82. ISBN<span>&nbsp;</span><bdi>9780857113382</bdi>.</cite></span></li><li id="cite_note-TI2016-8"> <span id="mw-reference-text-cite_note-TI2016-8" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.ti.ubc.ca/2016/06/28/99-comparative-effectiveness-proton-pump-inhibitors/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.ti.ubc.ca/2016/06/28/99-comparative-effectiveness-proton-pump-inhibitors/'" tppabs="http://www.ti.ubc.ca/2016/06/28/99-comparative-effectiveness-proton-pump-inhibitors/" class="external text external">"<span>[</span>99<span>]</span> Comparative effectiveness of proton pump inhibitors"</a>. <i>Therapeutics Initiative</i>. 28 June 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">14 July</span> 2016</span>.</cite></span></li><li id="cite_note-9"> <span id="mw-reference-text-cite_note-9" class="mw-reference-text"><cite id="CITEREFFischerGanellin2006" class="citation book cs1">Fischer, Jnos; Ganellin, C. Robin (2006). <a href="javascript:if(confirm('https://books.google.ca/books?id=FjKfqkaKkAAC&pg=PA445  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.ca/books?id=FjKfqkaKkAAC&pg=PA445'" tppabs="https://books.google.ca/books?id=FjKfqkaKkAAC&pg=PA445" class="external text external"><i>Analogue-based Drug Discovery</i></a>. John Wiley &amp; Sons. p.<span>&nbsp;</span>445. ISBN<span>&nbsp;</span><bdi>9783527607495</bdi>.</cite></span></li><li id="cite_note-NADAC2019-10"> <span id="mw-reference-text-cite_note-NADAC2019-10" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://data.medicaid.gov/Drug-Pricing-and-Payment/NADAC-as-of-2019-02-27/s7c9-pfa6  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://data.medicaid.gov/Drug-Pricing-and-Payment/NADAC-as-of-2019-02-27/s7c9-pfa6'" tppabs="https://data.medicaid.gov/Drug-Pricing-and-Payment/NADAC-as-of-2019-02-27/s7c9-pfa6" class="external text external">"NADAC as of 2019-02-27"</a>. <i>Centers for Medicare and Medicaid Services</i><span class="reference-accessdate">. Retrieved <span class="nowrap">3 March</span> 2019</span>.</cite></span></li><li id="cite_note-11"> <span id="mw-reference-text-cite_note-11" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://clincalc.com/DrugStats/Top300Drugs.aspx  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://clincalc.com/DrugStats/Top300Drugs.aspx'" tppabs="https://clincalc.com/DrugStats/Top300Drugs.aspx" class="external text external">"The Top 300 of 2020"</a>. <i>ClinCalc</i><span class="reference-accessdate">. Retrieved <span class="nowrap">11 April</span> 2020</span>.</cite></span></li><li id="cite_note-12"> <span id="mw-reference-text-cite_note-12" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://clincalc.com/DrugStats/Drugs/RabeprazoleSodium  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://clincalc.com/DrugStats/Drugs/RabeprazoleSodium'" tppabs="https://clincalc.com/DrugStats/Drugs/RabeprazoleSodium" class="external text external">"Rabeprazole Sodium - Drug Usage Statistics"</a>. <i>ClinCalc</i><span class="reference-accessdate">. Retrieved <span class="nowrap">11 April</span> 2020</span>.</cite></span></li><li id="cite_note-Dadabhai_review-13"> <span id="mw-reference-text-cite_note-Dadabhai_review-13" class="mw-reference-text"><cite id="CITEREFDadabhaiFriedenberg2009" class="citation journal cs1">Dadabhai, Alia; Friedenberg, Frank K (17 January 2009). "Rabeprazole: a pharmacologic and clinical review for acid-related disorders". <i>Expert Opinion on Drug Safety</i>. <b>8</b> (1): 119–126. doi:<a href="javascript:if(confirm('https://doi.org/10.1517%2F14740330802622892  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1517%2F14740330802622892'" tppabs="https://doi.org/10.1517%2F14740330802622892" class="external text external">10.1517/14740330802622892</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/19236223  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/19236223'" tppabs="https://pubmed.ncbi.nlm.nih.gov/19236223" class="external text external">19236223</a>.</cite></span></li><li id="cite_note-Change_et_al_obesity_gerd-14"> <span id="mw-reference-text-cite_note-Change_et_al_obesity_gerd-14" class="mw-reference-text"><cite id="CITEREFChangFriedenberg2014" class="citation journal cs1">Chang, Paul; Friedenberg, Frank (March 2014). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3920303  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3920303'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3920303" class="external text external">"Obesity and GERD"</a>. <i>Gastroenterology Clinics of North America</i>. <b>43</b> (1): 161–173. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.gtc.2013.11.009  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.gtc.2013.11.009'" tppabs="https://doi.org/10.1016%2Fj.gtc.2013.11.009" class="external text external">10.1016/j.gtc.2013.11.009</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3920303  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3920303'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3920303" class="external text external">3920303</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/24503366  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/24503366'" tppabs="https://pubmed.ncbi.nlm.nih.gov/24503366" class="external text external">24503366</a>.</cite></span></li><li id="cite_note-pmid29562147-15"> <span id="mw-reference-text-cite_note-pmid29562147-15" class="mw-reference-text"><cite id="CITEREFChoiKookKimCho2018" class="citation journal cs1">Choi IJ, Kook MC, Kim YI, Cho SJ, Lee JY, Kim CG, Park B, Nam BH (March 2018). <a href="javascript:if(confirm('https://doi.org/10.1056/NEJMoa1708423  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1056/NEJMoa1708423'" tppabs="https://doi.org/10.1056/NEJMoa1708423" class="external text external">"Helicobacter pylori Therapy for the Prevention of Metachronous Gastric Cancer"</a>. <i>N. Engl. J. Med</i>. <b>378</b> (12): 1085–1095. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1056%2FNEJMoa1708423  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1056%2FNEJMoa1708423'" tppabs="https://doi.org/10.1056%2FNEJMoa1708423" class="external text external">10.1056/NEJMoa1708423</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/29562147  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/29562147'" tppabs="https://pubmed.ncbi.nlm.nih.gov/29562147" class="external text external">29562147</a>.</cite></span></li><li id="cite_note-Rabeprazole_Drug_Approval-16"> <span id="mw-reference-text-cite_note-Rabeprazole_Drug_Approval-16" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/020973Orig1s009.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/020973Orig1s009.pdf'" tppabs="https://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/020973Orig1s009.pdf" class="external text external">"Application Number 20-973/S-009"</a> <span class="cs1-format">(PDF)</span>. Center for Drug Evaluation and Research<span class="reference-accessdate">. Retrieved <span class="nowrap">13 October</span> 2017</span>.</cite></span></li><li id="cite_note-Lombardo_and_Bonadonna-17"> <span id="mw-reference-text-cite_note-Lombardo_and_Bonadonna-17" class="mw-reference-text"><cite id="CITEREFLombardoBonadonna2015" class="citation journal cs1">Lombardo, Carla; Bonadonna, Patrizia (21 March 2015). <a href="javascript:if(confirm('https://doi.org/10.1007/s40521-015-0046-0  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007/s40521-015-0046-0'" tppabs="https://doi.org/10.1007/s40521-015-0046-0" class="external text external">"Hypersensitivity Reactions to Proton Pump Inhibitors"</a>. <i>Current Treatment Options in Allergy</i>. <b>2</b> (2): 110–123. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1007%2Fs40521-015-0046-0  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2Fs40521-015-0046-0'" tppabs="https://doi.org/10.1007%2Fs40521-015-0046-0" class="external text external">10.1007/s40521-015-0046-0</a></span>.</cite></span></li><li id="cite_note-Edurant_PI-18"> <span id="mw-reference-text-cite_note-Edurant_PI-18" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.edurant.com/shared/prescribing-information-edurant.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.edurant.com/shared/prescribing-information-edurant.pdf'" tppabs="http://www.edurant.com/shared/prescribing-information-edurant.pdf" class="external text external">"Edurant"</a> <span class="cs1-format">(PDF)</span>. Janssen Products<span class="reference-accessdate">. Retrieved <span class="nowrap">20 February</span> 2018</span>.</cite></span></li><li id="cite_note-Aciphex_Package_Insert-19"> <span id="mw-reference-text-cite_note-Aciphex_Package_Insert-19" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.accessdata.fda.gov/drugsatfda_docs/.../020973s035204736s005lbl.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.accessdata.fda.gov/drugsatfda_docs/.../020973s035204736s005lbl.pdf'" tppabs="https://www.accessdata.fda.gov/drugsatfda_docs/.../020973s035204736s005lbl.pdf" class="external text external">"Aciphex Package Insert"</a> <span class="cs1-format">(PDF)</span>. Eisai Inc<span class="reference-accessdate">. Retrieved <span class="nowrap">17 October</span> 2017</span>.</cite></span></li><li id="cite_note-Livertox_Rabeprazole-20"> <span id="mw-reference-text-cite_note-Livertox_Rabeprazole-20" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://livertox.nih.gov/Rabeprazole.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://livertox.nih.gov/Rabeprazole.htm'" tppabs="https://livertox.nih.gov/Rabeprazole.htm" class="external text external">"Rabeprazole"</a>. <i>livertox.nih.gov</i>. U.S. National Library of Medicine<span class="reference-accessdate">. Retrieved <span class="nowrap">13 October</span> 2017</span>.</cite></span></li><li id="cite_note-Ahn_et_al-21"> <span id="mw-reference-text-cite_note-Ahn_et_al-21" class="mw-reference-text"><cite id="CITEREFAhnEomJeonPark2013" class="citation journal cs1">Ahn, Jeong Soo; Eom, Chun-Sick; Jeon, Christie Y; Park, Sang Min (28 April 2013). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3646149  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3646149'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3646149" class="external text external">"Acid suppressive drugs and gastric cancer: A meta-analysis of observational studies"</a>. <i>World Journal of Gastroenterology</i>. <b>19</b> (16): 2560–2568. doi:<a href="javascript:if(confirm('https://doi.org/10.3748%2Fwjg.v19.i16.2560  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.3748%2Fwjg.v19.i16.2560'" tppabs="https://doi.org/10.3748%2Fwjg.v19.i16.2560" class="external text external">10.3748/wjg.v19.i16.2560</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/1007-9327  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/1007-9327'" tppabs="https://www.worldcat.org/issn/1007-9327" class="external text external">1007-9327</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3646149  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3646149'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3646149" class="external text external">3646149</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/23674860  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/23674860'" tppabs="https://pubmed.ncbi.nlm.nih.gov/23674860" class="external text external">23674860</a>.</cite></span></li><li id="cite_note-NLM_Toxnet_Rabeprazole-22"> <span id="mw-reference-text-cite_note-NLM_Toxnet_Rabeprazole-22" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+7321  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+7321'" tppabs="https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+7321" class="external text external">"Rabeprazole – National Library of Medicine HSDB Database"</a>. <i>toxnet.nlm.nih.gov</i>. National Library of Medicine<span class="reference-accessdate">. Retrieved <span class="nowrap">5 October</span> 2017</span>.</cite></span></li><li id="cite_note-Olbe_Pibrant_p161-23"> <span id="mw-reference-text-cite_note-Olbe_Pibrant_p161-23" class="mw-reference-text"><cite id="CITEREFPilbrant1999" class="citation book cs1">Pilbrant, Ake (1999). "Pharmaceutical considerations".  In Olbe, L (ed.). <i>Proton Pump Inhibitors</i>. Proto: Birkhauser. p.<span>&nbsp;</span>161.</cite></span></li><li id="cite_note-PharmGKB_Label_for_Rab-24"> <span id="mw-reference-text-cite_note-PharmGKB_Label_for_Rab-24" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.pharmgkb.org/label/PA166104848  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.pharmgkb.org/label/PA166104848'" tppabs="https://www.pharmgkb.org/label/PA166104848" class="external text external">"Annotation of FDA Label for rabeprazole and CYP2C19"</a>. <i>pharmgkb.org</i>. NIH/NIGMS<span class="reference-accessdate">. Retrieved <span class="nowrap">9 October</span> 2017</span>.</cite></span></li><li id="cite_note-Synth1-25"> <span id="mw-reference-text-cite_note-Synth1-25" class="mw-reference-text"><cite id="CITEREFTagamiChikuSohda1993" class="citation journal cs1">Tagami, K.; Chiku, S.; Sohda, S. (1993). "Synthesis of 14C-labelled sodium pariprazole (E3810)". <i>Journal of Labelled Compounds and Radiopharmaceuticals</i>. <b>33</b> (9): 849–852. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2Fjlcr.2580330908  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2Fjlcr.2580330908'" tppabs="https://doi.org/10.1002%2Fjlcr.2580330908" class="external text external">10.1002/jlcr.2580330908</a>.</cite></span></li><li id="cite_note-Synth2-26"> <span id="mw-reference-text-cite_note-Synth2-26" class="mw-reference-text">S. Souda et al., <span class="citation patent"><a href="javascript:if(confirm('https://worldwide.espacenet.com/textdoc?DB=EPODOC&IDX=EP268956  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://worldwide.espacenet.com/textdoc?DB=EPODOC&IDX=EP268956'" tppabs="https://worldwide.espacenet.com/textdoc?DB=EPODOC&IDX=EP268956" class="external text external">EP 268956</a></span>; eidem, <span><a href="javascript:if(confirm('https://www.google.com/patents/US5045552  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.google.com/patents/US5045552'" tppabs="https://www.google.com/patents/US5045552" class="external text external">U.S. Patent 5,045,552</a></span> (1988, 1991 both to Eisai).</span></li><li id="cite_note-StatReview_1-27"> <span id="mw-reference-text-cite_note-StatReview_1-27" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/21-456_Aciphex_Statr_P1.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/21-456_Aciphex_Statr_P1.pdf'" tppabs="https://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/21-456_Aciphex_Statr_P1.pdf" class="external text external">"Medical Review and Statistical Review: NDA #21-456"</a> <span class="cs1-format">(PDF)</span>. <i>www.accessdata.fda.gov</i>. Center for Drug Evaluation and Research<span class="reference-accessdate">. Retrieved <span class="nowrap">3 December</span> 2017</span>.</cite></span></li><li id="cite_note-FDA_approval_label_for_generic-28"> <span id="mw-reference-text-cite_note-FDA_approval_label_for_generic-28" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=076822  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=076822'" tppabs="https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=076822" class="external text external">"Drugs@FDA"</a>. <i>accessdata.fda.gov</i>. US FDA<span class="reference-accessdate">. Retrieved <span class="nowrap">9 October</span> 2017</span>.</cite></span></li><li id="cite_note-UK_label_for_generic-29"> <span id="mw-reference-text-cite_note-UK_label_for_generic-29" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.mhra.gov.uk/home/groups/spcpil/documents/spcpil/con1480053700073.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.mhra.gov.uk/home/groups/spcpil/documents/spcpil/con1480053700073.pdf'" tppabs="http://www.mhra.gov.uk/home/groups/spcpil/documents/spcpil/con1480053700073.pdf" class="external text external">"Rabeprazole SPC"</a> <span class="cs1-format">(PDF)</span>. MHRA. 15 January 2013.</cite></span></li><li id="cite_note-Indian_Approvals-30"> <span id="mw-reference-text-cite_note-Indian_Approvals-30" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.cdsco.nic.in/writereaddata/list_of_drugs_approved_during_2001.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.cdsco.nic.in/writereaddata/list_of_drugs_approved_during_2001.htm'" tppabs="http://www.cdsco.nic.in/writereaddata/list_of_drugs_approved_during_2001.htm" class="external text external">"List Of Drugs Approved During 1999"</a>. <i>www.cdsco.nic.in</i>. Ministry of Health and Family Welfare<span class="reference-accessdate">. Retrieved <span class="nowrap">2 December</span> 2017</span>.</cite></span></li><li id="cite_note-Aciphex_Press_Release-31"> <span id="mw-reference-text-cite_note-Aciphex_Press_Release-31" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.evaluategroup.com/Universal/View.aspx?type=Story&id=21400  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.evaluategroup.com/Universal/View.aspx?type=Story&id=21400'" tppabs="http://www.evaluategroup.com/Universal/View.aspx?type=Story&id=21400" class="external text external">"Aciphex (rabeprazole sodium) Approved For Treatment Of Symptomatic Gastroesophageal Reflux Disease (GERD) | Evaluate"</a>. <i>www.evaluategroup.com</i>. Evaluate Ltd<span class="reference-accessdate">. Retrieved <span class="nowrap">2 December</span> 2017</span>.</cite></span></li><li id="cite_note-brands-32"> <span id="mw-reference-text-cite_note-brands-32" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.drugs.com/international/rabeprazole.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/international/rabeprazole.html'" tppabs="https://www.drugs.com/international/rabeprazole.html" class="external text external">"Rabeprazole international brands"</a>. Drugs.com<span class="reference-accessdate">. Retrieved <span class="nowrap">25 September</span> 2017</span>.</cite></span></li><li id="cite_note-Strand_et_al_2017-33"> <span id="mw-reference-text-cite_note-Strand_et_al_2017-33" class="mw-reference-text"><cite id="CITEREFStrandKimPeura2017" class="citation journal cs1">Strand, Daniel S.; Kim, Daejin; Peura, David A. (15 January 2017). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5221858  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5221858'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5221858" class="external text external">"25 Years of Proton Pump Inhibitors: A Comprehensive Review"</a>. <i>Gut and Liver</i>. <b>11</b> (1): 27–37. doi:<a href="javascript:if(confirm('https://doi.org/10.5009%2Fgnl15502  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.5009%2Fgnl15502'" tppabs="https://doi.org/10.5009%2Fgnl15502" class="external text external">10.5009/gnl15502</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5221858  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5221858'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5221858" class="external text external">5221858</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/27840364  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/27840364'" tppabs="https://pubmed.ncbi.nlm.nih.gov/27840364" class="external text external">27840364</a>.</cite></span></li></ol></div></div>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="External_links">External links</h2></summary>
    
<ul><li><cite class="citation web cs1"><a href="javascript:if(confirm('https://druginfo.nlm.nih.gov/drugportal/rn/117976-89-3  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://druginfo.nlm.nih.gov/drugportal/rn/117976-89-3'" tppabs="https://druginfo.nlm.nih.gov/drugportal/rn/117976-89-3" class="external text external">"Rabeprazole"</a>. <i>Drug Information Portal</i>. U.S. National Library of Medicine.</cite></li></ul>

<div role="navigation" class="navbox" aria-labelledby="Drugs_for_peptic_ulcer_and_GERD/GORD_(A02B)" style="padding:3px"><table class="nowraplinks mw-collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Drugs_for_peptic_ulcer_and_GERD/GORD_(A02B)" style="font-size:114%;margin:0 4em">Drugs for peptic ulcer and GERD/GORD (A02B)</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%">H<sub>2</sub> antagonists ("-tidine")</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Cimetidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cimetidine" title="Cimetidine">Cimetidine</a></li>
<li><a href="Famotidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Famotidine" title="Famotidine">Famotidine</a></li>
<li>Lafutidine</li>
<li>Lavoltidine (loxtidine)</li>
<li>Niperotidine</li>
<li><a href="Nizatidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Nizatidine" title="Nizatidine">Nizatidine</a></li>
<li><a href="Ranitidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ranitidine" title="Ranitidine">Ranitidine</a><sup>#</sup></li>
<li>Roxatidine</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Prostaglandins (E)/analogues ("-prost-")</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Misoprostol.htm" tppabs="https://ptable.com/wiki/compounds/A/Misoprostol" title="Misoprostol">Misoprostol</a></li>
<li>Enprostil</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Proton-pump inhibitors ("-prazole")</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Azeloprazole</li>
<li>Dexlansoprazole</li>
<li><a href="Esomeprazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Esomeprazole" title="Esomeprazole">Esomeprazole</a></li>
<li>Ilaprazole</li>
<li><a href="Lansoprazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Lansoprazole" title="Lansoprazole">Lansoprazole</a></li>
<li><a href="Omeprazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Omeprazole" title="Omeprazole">Omeprazole</a><sup>#</sup></li>
<li><a href="Pantoprazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Pantoprazole" title="Pantoprazole">Pantoprazole</a></li>
<li><span class="new">Picoprazole</span></li>
<li><a href="Rabeprazole.htm" tppabs="https://ptable.com/wiki/compounds/A/Rabeprazole" title="Rabeprazole">Rabeprazole</a></li>
<li>Tenatoprazole</li>
<li>Timoprazole</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Potassium-competitive acid blockers ("-prazan")</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><span class="new">Linaprazan</span></li>
<li>Revaprazan</li>
<li><span class="new">Soraprazan</span></li>
<li>Vonoprazan</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Others</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Aceglutamide aluminum</li>
<li>Acetoxolone</li>
<li>Alginic acid</li>
<li>Arbaclofen placarbil</li>
<li>Bismuth subcitrate</li>
<li><a href="Carbenoxolone.htm" tppabs="https://ptable.com/wiki/compounds/A/Carbenoxolone" title="Carbenoxolone">Carbenoxolone</a></li>
<li><a href="Cetraxate.htm" tppabs="https://ptable.com/wiki/compounds/A/Cetraxate" title="Cetraxate">Cetraxate</a></li>
<li>Gefarnate</li>
<li>Lesogaberan</li>
<li><a href="Pirenzepine.htm" tppabs="https://ptable.com/wiki/compounds/A/Pirenzepine" title="Pirenzepine">Pirenzepine</a></li>
<li>Proglumide</li>
<li><a href="Rebamipide.htm" tppabs="https://ptable.com/wiki/compounds/A/Rebamipide" title="Rebamipide">Rebamipide</a></li>
<li><a href="Sucralfate.htm" tppabs="https://ptable.com/wiki/compounds/A/Sucralfate" title="Sucralfate">Sucralfate</a></li>
<li>Sulglicotide</li>
<li><a href="Telenzepine.htm" tppabs="https://ptable.com/wiki/compounds/A/Telenzepine" title="Telenzepine">Telenzepine</a></li>
<li>Teprenone</li>
<li>Troxipide</li>
<li>Zinc L-carnosine</li>
<li>Zolimidine</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Combinations</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Bismuth subcitrate/metronidazole/tetracycline</li></ul>
</div></td></tr><tr><td colspan="2" class="navbox-list navbox-odd hlist" style="width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>See also: <i>Helicobacter pylori</i> eradication protocols</i></li></ul>
</div></td></tr><tr><td class="navbox-abovebelow" colspan="2" style="background: transparent; padding: 0px;"><div><div class="hlist">
<ul><li><sup>#</sup>WHO-EM</li>
<li><sup>‡</sup>Withdrawn from market</li>
<li>Clinical trials:
<ul><li><sup>†</sup>Phase III</li>
<li><sup>§</sup>Never to phase III</li></ul></li></ul>
</div></div></td></tr></tbody></table></div>


<p></p>











<style data-mw-deduplicate="TemplateStyles:r951705291">.mw-parser-output cite.citation{font-style:inherit}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-ws-icon a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg*/);background-repeat:no-repeat;background-size:12px;background-position:right .1em center}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:inherit;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{font-size:100%}.mw-parser-output .cs1-maint{display:none;color:#33aa33;margin-left:0.3em}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}</style>
    
</details></div>
        </div>
      </div>
    </div>
  </div>
  <script src="../-/j/js_modules/jsConfigVars.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jsConfigVars.js" class=""></script>
  <script src="../-/j/js_modules/startup.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/startup.js" class=""></script>
<script src="../-/j/js_modules/jquery.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jquery.js" class=""></script>
<script src="../-/j/js_modules/mediawiki.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/mediawiki.js" class=""></script>
<script src="../-/j/js_modules/site.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/site.js" class=""></script>
<script src="../-/j/js_modules/ext.cite.ux-enhancements.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/ext.cite.ux-enhancements.js" class=""></script>



</body></html>